Holen Sie sich die Stockscreener-App
0.00
100.00%
-7.04
Schlusskurs vom Vortag:
$7.04
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$1.08B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3.12M
KGV:
0.00
EPS:
-4.8149
Netto-Cashflow:
$-2.69M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$17.46
180 Life Sciences Corp Stock (ATNF) Company Profile
Firmenname
180 Life Sciences Corp
Sektor
Branche
Telefon
650-507-0669
Adresse
3000 EL CAMINO REAL, PALO ALTO
Vergleichen Sie ATNF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
0.00 | 1.08B | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.00 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.45 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.23 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
906.74 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.93 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-15 | Eingeleitet | Maxim Group | Buy |
180 Life Sciences Corp Aktie (ATNF) Neueste Nachrichten
180 Life Sciences Corp Stock Analysis and ForecastREITs Market Trends & Small Entry Trading Portfolio - earlytimes.in
How 180 Life Sciences Corp. Equity Warrant stock performs after earningsTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
Why 180 Life Sciences Corp. Equity Warrant stock remains resilient2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
How 180 Life Sciences Corp. stock benefits from global expansionJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com
Why analysts upgrade 180 Life Sciences Corp. stock2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Custom strategy builders for tracking 180 Life Sciences Corp. Equity WarrantEarnings Recap Summary & Reliable Price Action Trade Plans - newser.com
Can 180 Life Sciences Corp. stock sustain revenue growthMarket Weekly Review & High Conviction Buy Zone Picks - newser.com
Is 180 Life Sciences Corp. stock supported by strong fundamentalsMarket Growth Review & AI Driven Price Forecasts - newser.com
What is the fair value of 180 Life Sciences Corp. stock now2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Can 180 Life Sciences Corp. Equity Warrant stock maintain growth trajectoryTrade Performance Summary & Verified Swing Trading Watchlists - newser.com
Can volume confirm reversal in 180 Life Sciences Corp. Equity WarrantQuarterly Trade Summary & Fast Entry High Yield Tips - newser.com
What insider trading reveals about 180 Life Sciences Corp. stockJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
Short interest data insights for 180 Life Sciences Corp.2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
What dividend safety score for 180 Life Sciences Corp. stock2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Why 180 Life Sciences Corp. Equity Warrant stock could outperform in 2025Portfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Custom watchlist performance reports with 180 Life Sciences Corp.Market Growth Report & High Conviction Investment Ideas - newser.com
Is this a good reentry point in 180 Life Sciences Corp.July 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
Real time scanner hits for 180 Life Sciences Corp. explainedQuarterly Profit Review & Smart Allocation Stock Tips - newser.com
Will 180 Life Sciences Corp. stock continue upward momentum2025 Valuation Update & Fast Moving Stock Trade Plans - newser.com
How resilient is 180 Life Sciences Corp. stock in market downturns - newser.com
Leading vs lagging indicators on 180 Life Sciences Corp. Equity Warrant performanceAnalyst Downgrade & Weekly Watchlist for Hot Stocks - newser.com
Finanzdaten der 180 Life Sciences Corp-Aktie (ATNF)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.13%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):